Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) EBT Margin (2016 - 2025)

Lisata Therapeutics filings provide 11 years of EBT Margin readings, the most recent being 2272.31% for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 181131.0% year-over-year to 2272.31%, compared with a TTM value of 8774.0% through Dec 2025, down 669570.0%, and an annual FY2025 reading of 8774.0%, down 669570.0% over the prior year.
  • EBT Margin hit 2272.31% in Q4 2025 for Lisata Therapeutics, up from 6655.71% in the prior quarter.
  • The five-year high for EBT Margin was 461.0% in Q4 2024, with the low at 6655.71% in Q2 2025.